Arctigenin Attenuates Ischemia/Reperfusion Induced Ventricular Arrhythmias by Decreasing Oxidative Stress in Rats

Cell Physiol Biochem. 2018;49(2):728-742. doi: 10.1159/000493038. Epub 2018 Aug 30.

Abstract

Background/aims: Arctigenin (ATG) has been shown to possess anti-inflammatory, immunemodulatory, anti-viral, anti-microbial, anti-carcinogenic, vasodilatory and anti-platelet aggregation properties. However, the protective role of ATG in prevention of arrhythmias induced by myocardial ischemia/reperfusion is unknown. The aim of this study was to investigate the anti-arrhythmia effect of ATG in an ischemia/reperfusion injured rat heart model and explore the related mechanisms.

Methods: Rats were randomly exposed to sham operation, myocardial ischemia/ reperfusion (MI/R) alone, ATG+ MI/R, pretreated with ATG in low (12.5 mg/kg/day), medium (50 mg/kg/day) and high dose (200 mg/kg/day), respectively. Ventricular arrhythmias were assessed. The activity of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and the level of malondialdehyde (MDA) in myocardial tissue were determined by chemical analysis.

Results: Compared to MI/R, rats pretreated with ATG in doses of 50 mg/kg/day and 200 mg/kg/day showed significantly reduced incidence and duration of ventricular fibrillation, ventricular tachycardia and ventricular ectopic beat (VEB), and decreased the arrhythmia score during the 30-min ischemia. Incidence and duration of ventricular tachycardia, infarction size and arrhythmia scores in these groups were significantly decreased during the 120-min reperfusion. No ventricular fibrillation occurred during the period of reperfusion. Rats pretreated with ATG in doses of 50 mg/kg/day and 200 mg/kg/ day markedly enhanced the activities of antioxidant enzymes SOD and GSH-Px, reduced the level of MDA. No differences were observed between the group pretreated with a low dose of ATG and the sham group. Administration of ATG significantly increased the expression of antioxidant stress protein Nrf2, Trx1 and Nox1.

Conclusion: Our data suggested that ATG plays anti-arrhythmia role in ischemia/reperfusion injury, which is probably associated with attenuating oxidative stress by Nrf2 signaling pathway.

Keywords: Arctigenin; Arrhythmias; Ischemia reperfusion; Nrf2 signaling; Oxidative stress.

MeSH terms

  • Animals
  • Arrhythmias, Cardiac / etiology
  • Arrhythmias, Cardiac / metabolism
  • Arrhythmias, Cardiac / prevention & control*
  • Disease Models, Animal
  • Furans / pharmacology*
  • Furans / therapeutic use
  • Glutathione Peroxidase / metabolism
  • Lignans / pharmacology*
  • Lignans / therapeutic use
  • Male
  • Malondialdehyde / metabolism
  • Myocardial Infarction / pathology
  • Myocardium / metabolism
  • NADPH Oxidase 1 / metabolism
  • NF-E2-Related Factor 2 / metabolism
  • Oxidative Stress / drug effects*
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / complications
  • Superoxide Dismutase / metabolism
  • Thioredoxins / metabolism

Substances

  • Furans
  • Lignans
  • NF-E2-Related Factor 2
  • Txn1 protein, rat
  • Malondialdehyde
  • Thioredoxins
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • NADPH Oxidase 1
  • NOX1 protein, rat
  • arctigenin